|
|
Profile
|
Delegates :
Norio Uematsu |
|
Incorporated :
March 22 , 2021 |
Paid in Capital :
Million yen |
Employees :
2 人 |
Address :
Gokoudori 8-1-6, Chuou-ku, Kobe HYOGO
〒6510087
|
TEL/FAX :
+81-78-600-2623 / |
URL：
https://orchard-bio.jp/en/ |
Attachment :
|
Mission/Background :
Orchard Bio Inc. was established in March 2022 upon the corporate philosophy of "Hopeful life to all, through our developing technology in the regenerative medicine."
We are developing hAP cells (holding Active Pharmaceutical Ingredient cells), combination pharmaceutical products consisting of "drug" and "living cell". |
|
Technology & Business
|
The hAP cell we are developing is a combinational pharmaceutical product composing of conventional drugs, which is encapsulated in PLGA, and human cells. Once administrated, the hAP cells accumulate at the injury sites along the composing cellular intrinsic function and release the encapsulated drug.
As tremendous hAP cell types can be developed upon the selection of adequate drug and cell, variety of diseases are potential target of the hAP cells.
Our first pipeline of the hAP (statin) cell progress to in vivo efficacy study and soon steps forward to set-up for GMP-complied manufacturing process and GLP-complied safety studies. We have also started collaboration with Japanese pharmaceutical company to develop different hAP cells using various drug candidates.
|
|
Products & Service
|
Products & Service Name
|
Stage
|
Outline
|
Milestone
|
hAP (statin) cell
|
Discovery
|
MSC incorporated with PLGA nanoparticles in which simvastatin is embedded
|
License out of the hAP (statin) cell
|
hAP (minoxidil) cell
|
Discovery
|
MSC incorporated with PLGA nanoparticles in which minoxidil is embedded
|
in vitro efficacy in hAP (minoxidil) cell
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Highlights
|
Collaboration with Astellas Pharma Inc. on specific hAP cell development .
Start of development of new hAP cells, hAP (minoxidil) cells
Collection of data for the purpose of patent application
|
|
Alliance strategy
|
We are seeking a company to license out the hAP (statin) cell
We are starting the development of hAP (cyclosporine) and seeking a partner to collaborate this project
We are looking for any proposals to develop hAP cells using drugs you hold as its toxicity.
|
|
|